BetterLife Pharma Inc. (BETRF)

Market Cap	39.82M +307.9%
Revenue (ttm)	n/a
Net Income	-1.39M
EPS	-0.01
Shares Out	161.89M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	49,585
Open	0.25384
Previous Close	0.2553
Day's Range	0.2424 - 0.25494
52-Week Range	0.0276 - 0.3311
Beta	0.22
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 25, 2026

About BetterLife Pharma

BetterLife Pharma Inc., a biotechnology company, engages in the development of psychedelic-derived compounds. It focuses on developing and commercializing BETR-001, a non-hallucinogenic and non-controlled LSD derivative to treat neuro-psychiatric and neurological disorders. Its products also comprise MM-001, a topical cream for local intravaginal use to treat HPV-induced cervical intraepithelial neoplasia; and MM-003, a patent pending proprietary interferon alpha-2b inhalation formulation. The company was formerly known as Pivot Pharmaceuticals...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2002
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: BETRF

Financial Performance

Financial numbers in CAD

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Sep 19, 2026

Data Sources Report a data error